Treatment of Severe Hyponatremia

被引:92
|
作者
Sterns, Richard H. [1 ]
机构
[1] Univ Rochester, Sch Med & Dent, Rochester Gen Hosp, Rochester, NY USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2018年 / 13卷 / 04期
关键词
osmolality; hypokalemia; clinical nephrology; humans; Animals; United States; hyponatremia; Brain Edema; Sodium; Water-Electrolyte Imbalance; Demyelinating Diseases; Osmosis; Models; Animal; electrolytes; OSMOTIC DEMYELINATION SYNDROME; CENTRAL PONTINE MYELINOLYSIS; RAPID CORRECTION; EXTRAPONTINE MYELINOLYSIS; HYPERTONIC SALINE; PROFOUND HYPONATREMIA; HOSPITALIZED-PATIENTS; SERUM SODIUM; OVERCORRECTION; COMPLICATIONS;
D O I
10.2215/CJN.10440917
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Patients with severe (serum sodium 120 mEq/L), symptomatic hyponatremia can develop life-threatening or fatal complications from cerebral edema if treatment is inadequate and permanent neurologic disability from osmotic demyelination if treatment is excessive. Unfortunately, as is true of all electrolyte disturbances, there are no randomized trials to guide the treatment of this challenging disorder. Rather, therapeutic decisions rest on physiologic principles, animal models, observational studies, and single-patient reports. European guidelines and recommendations of an American Expert panel have come to similar conclusions on how much correction of hyponatremia is enough and how much is too much, but there are important differences. We review the evidence supporting these recommendations, identifying areas that rest on relatively solid ground and highlighting areas in greatest need of additional data.
引用
收藏
页码:641 / 649
页数:9
相关论文
共 50 条
  • [31] Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice
    Workeneh, Biruh T.
    Meena, Priti
    Christ-Crain, Mirjam
    Rondon-Berrios, Helbert
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (02): : 85 - 101
  • [32] A Patient With Severe Hyponatremia and Hypokalemia: Osmotic Demyelination Following Potassium Repletion
    Berl, Tomas
    Rastegar, Asghar
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : 742 - 748
  • [33] Osmotic demyelination syndrome after correction of severe hyponatremia associated with pituitrin
    Xu, Dan Hua
    Yuan, Min
    Wang, Jian Wen
    Hu, Yun Zhen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (05) : 408 - 411
  • [34] Management of Hyponatremia in the ICU
    Sterns, Richard H.
    Hix, John K.
    Silver, Stephen M.
    CHEST, 2013, 144 (02) : 672 - 679
  • [35] Acute and Chronic Hyponatremia
    Kheetan, Murad
    Ogu, Iheanyichukwu
    Shapiro, Joseph, I
    Khitan, Zeid J.
    FRONTIERS IN MEDICINE, 2021, 8
  • [36] Hyponatremia is associated with more severe biliary disease
    Zobel, Michael John
    Stewart, Lygia
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 12 (02): : 45 - 54
  • [37] Treatment algorithm: management of hyponatremia in acute and emergency medicine
    Kasper, Philipp
    Burst, Volker
    Michels, Guido
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2023, 118 (03) : 185 - 188
  • [38] Effects of correction rate for severe hyponatremia in the intensive care unit on patient outcomes
    Kinoshita, Takahiro
    Mlodzinski, Eric
    Xiao, Qian
    Sherak, Raphael
    Raines, Nathan H.
    Celi, Leo A.
    JOURNAL OF CRITICAL CARE, 2023, 77
  • [39] Risk factors for overcorrection of severe hyponatremia: a post hoc analysis of the SALSA trial
    Yang, Huijin
    Yoon, Songuk
    Kim, Eun Jung
    Seo, Jang Won
    Koo, Ja-Ryong
    Oh, Yun Kyu
    Jo, You Hwan
    Kim, Sejoong
    Baek, Seon Ha
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 (03) : 298 - 309
  • [40] Treatment of hyponatremia: the role of lixivaptan
    Liamis, George
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (04) : 431 - 441